BSP:BLAU3 (Brazil)  
Blau Farmaceutica SA logo

Blau Farmaceutica SA

R$ 32.00 (-1.87%) Oct 3
P/E:
18.31
P/B:
3.34
Market Cap:
R$ 5.69B ($ 1.10B)
Enterprise V:
R$ 5.21B ($ 1.01B)
Volume:
1.79M
Avg Vol (2M):
481.78K
Volume:
1.79M
Market Cap R$:
5.69B
Market Cap $:
1.10B
PE Ratio:
18.31
Avg Vol (2-Month):
481.78K
Enterprise Value R$:
5.21B
Enterprise Value $:
1.01B
PB Ratio:
3.34
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Blau Farmaceutica SA is a biotechnological company in Latin America, producing high complexity and hospital medications fundamental for human health - biological, specialty, oncological, pharma/ dermo-cosmetics. Business is organized into two operating segments being Institutional and Retail. The Institutional business segment consists of drugs applied in specific treatments in public and private hospitals and clinics, with a broad portfolio of biological, oncology, and specialties products, among others. The Retail segment caters to the pharmaceutical retail channel, which consists of a less varied portfolio. Geographically it serves Colombia, Uruguay Chile and others whilst generating key revenue from domestic sales in Brazil.
Name Current Vs Industry Vs History
Cash-To-Debt 2.52
Equity-to-Asset 0.72
Debt-to-Equity 0.18
Debt-to-EBITDA 0.69
Interest Coverage 11.95
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.22
Distress
Grey
Safe
Beneish M-Score -2.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 51.27
9-Day RSI 51.19
14-Day RSI 52.28
6-1 Month Momentum % 11.28
12-1 Month Momentum % -27.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.3
Quick Ratio 3.04
Cash Ratio 2.03
Days Inventory 223.99
Days Sales Outstanding 91.64
Days Payable 51.66

Financials

BSP:BLAU3's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 1,348.097
EPS (TTM) (R$) 1.748
Beta 0
Volatility % 38.83
14-Day RSI 52.28
14-Day ATR (R$) 1.397393
20-Day SMA (R$) 32.067
12-1 Month Momentum % -27.78
52-Week Range (R$) 21.55 - 44.98
Shares Outstanding (Mil) 177.83

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Blau Farmaceutica SA Filings

Document Form Filing Date
No Filing Data

Blau Farmaceutica SA Analysis

Share your research